Authors
Loading...
Clinical trial demonstrates high clinical efficacy and safety of cefoxitin in acute respiratory infections, indicating its viability as an effective intravenous antibacterial therapy.
Weinstein et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: